BACKGROUND: Marginal ulceration (MU) is a significant cause of morbidity after Roux-en-Y gastric bypass (RYGB). Proton pump inhibitor (PPI) therapy is the mainstay of treatment…
BACKGROUND: Both steatotic liver disease and bariatric surgery are becoming increasingly common in light of the rising obesity epidemic. Yet, there is a paucity of literature describing the impact of bariatric surgery on cirrhosis-related outcomes…